At McDaniel Nutrition Therapy, our dietitians have been receiving more and more questions about peptides.
Not just from clients, but from friends, colleagues, and across social media.
People are curious about peptides for:
- building muscle
- reducing body fat
- improving sleep
- boosting mood
- speeding recovery
- skin rejuvenation
Many people first remember learning about peptides in a basic chemistry course.
So how did something that once appeared in a college lecture suddenly become a popular intervention in the wellness space and a potential “solution” for so many aspects of aging?
To answer that question, it helps to start with the basics.
What Is a Peptide?
A peptide is a short chain of amino acids, the building blocks of protein.
Our bodies naturally produce peptides that act as signaling molecules. They function a bit like text messages between organs and tissues, helping regulate key physiological processes.
Examples include:
- Insulin, a peptide hormone that regulates blood sugar
- Glucagon-like peptide-1 (GLP-1), involved in appetite and glucose regulation
- Growth hormone–releasing hormone (GHRH), which stimulates growth hormone release
Natural peptides in the body typically act quickly and are then broken down, often within minutes.
Modern medicine has learned how to modify certain peptides so they last longer in the body. That’s how medications like GLP-1 receptor agonists work. These medications are engineered versions of naturally occurring peptides designed to remain active long enough to produce meaningful metabolic changes.
Importantly, FDA-approved GLP-1 medications have undergone extensive human clinical trials to evaluate both safety and effectiveness.
That level of testing and regulatory oversight has not yet occurred for many of the peptides currently marketed for body composition or anti-aging.
Peptide Drugs Being Marketed for “Optimization”
Several peptide therapies are currently being promoted for muscle gain, fat loss, recovery, and longevity.
Some commonly discussed examples include:
CJC-1295
Marketed as: boosting growth hormone, building muscle, reducing fat, improving recovery
What it is: a synthetic analogue of growth hormone–releasing hormone.
Most body composition data comes from animal studies or extremely small human trials. There are currently no robust long-term studies in healthy adults using it for performance or aesthetic goals.
Ipamorelin
Marketed as: a “safer” growth hormone stimulator
What it is: a growth hormone secretagogue that stimulates the pituitary gland.
Existing data are limited and primarily short-term. Large-scale, long-term human safety trials for optimization use have not been conducted.
BPC-157
Marketed as: healing gut lining, accelerating tendon repair, reducing inflammation
What it is: a synthetic fragment derived from a protein found in gastric juice.
Most supportive research has been conducted in rodents, and human trials remain sparse and small.
Marketing language around these compounds often includes words like:
Repair
Restore
Rejuvenate
Optimize
But biological systems are complex.
Stimulating growth hormone pathways or cellular repair mechanisms is not like flipping a simple switch. Hormonal systems interact with one another, and altering one pathway can influence many others.
Right now, we simply do not have strong long-term data on the effects of chronically manipulating these pathways in otherwise healthy adults.
That doesn’t automatically mean harm.
But it does mean uncertainty.
A Word About Compounded Peptides (Including GLP-1s)
Another important layer in the peptide conversation involves compounded medications.
Some clinics offer compounded GLP-1 medications or other peptide injections when brand-name medications are expensive or unavailable.
Compounding pharmacies do play an important role in medicine. They can create customized formulations when a patient needs a specific dose or cannot tolerate certain ingredients.
However, compounded medications differ from FDA-approved medications in important ways.
Compounded medications:
- Are not FDA approved
- Do not undergo large clinical trials before use
- Are not held to the same large-scale manufacturing consistency standards
Medications developed through the FDA approval pathway typically undergo:
- Preclinical laboratory and animal research
- Phase 1 trials (safety and dosing)
- Phase 2 trials (expanded safety and early effectiveness)
- Phase 3 trials (large randomized controlled trials)
- Ongoing post-marketing safety monitoring
This process often takes many years and helps clarify:
- Mechanism of action
- Appropriate dosing
- Drug interactions
- Short- and long-term safety
- Rare but serious side effects
With compounded injectable medications, consistency and sterility depend heavily on the individual pharmacy’s processes.
This can lead to variation in potency, formulation, or sourcing between batches.
Research on Peptide Product Variability
Testing data also raises important quality questions.
An Austin-based peptide testing company, Finnrick Analytics, analyzed over 5,000 peptide samples from more than 170 vendors.
They found significant variability between vendors and even between batches from the same company.In testing of BPC-157:
- Some vials labeled as the peptide contained none of the compound
- Others ranged in purity from 82% to 100%
This doesn’t mean every compounded medication is unsafe.
But it does highlight that the regulatory pathway is more limited, especially when peptides are sold outside traditional FDA oversight.
And when injectable substances influence hormonal signaling, precision and sterility matter.
Questions Worth Asking Before Trying Peptide Therapy
If someone recommends a peptide for muscle growth, fat loss, recovery, or mood, it may be helpful to ask:
- Has this been studied in large human clinical trials?
- What long-term safety data exist?
- Is it FDA approved for this use?
- Is the medication compounded?
- What quality controls are in place?
- What happens when treatment stops?
- What other hormonal systems might be affected?
If those answers are unclear, it may not be because someone is asking the wrong questions.
Often, it simply means the data does not yet exist.
And without long-term data, individuals are essentially participating in an experiment.
Innovation Matters — But So Does Evidence
At McDaniel Nutrition Therapy, our St. Louis registered dietitians support scientific innovation and emerging therapies when supported by strong evidence.
Advocating for health and exploring new treatment pathways can be empowering.
But there is a difference between carefully studied medical innovation and rapid expansion driven by market demand.
The wellness industry has strong financial incentives around many peptide therapies.
Healthcare providers across the country are increasingly being approached with offers to add peptide treatments to their practices.
Financial opportunity does not automatically make something harmful.
But it should encourage thoughtful consideration.
Because patients deserve:
- Transparency
- Evidence-based recommendations
- Clear discussions of risks and benefits
- Long-term human safety data
Before choosing to inject, ingest, or invest in any therapy.
Optimization culture often promises shortcuts.
Human physiology rarely offers them without tradeoffs.
Before introducing new substances into the body in the name of muscle, metabolism, or longevity, it can help to slow down, ask informed questions, and ensure the excitement around something new doesn’t outpace the evidence behind it.
About McDaniel Nutrition Therapy
McDaniel Nutrition Therapy is a team of registered dietitians in St. Louis specializing in evidence-based nutrition counseling, including digestive health, weight management, metabolic health, and personalized nutrition planning.If you are looking for guidance from a St. Louis dietitian, our team works with individuals to evaluate emerging health trends, review the research, and make informed decisions that support long-term health.